The results revealed that the genes upregulated when the enhancer of zeste homolog 2 (EZH2) was knocked down were significantly enriched into the transcriptome of the PCa tumors with low EHF expression, while the genes downregulated were enriched into the high EHF subgroup (Fig. 4A). The gene discussed is EZH2; the disease is posterior cortical atrophy.